Phase 2 single-arm study on the safety of maintenance niraparib in Japanese patients with platinum-sensitive relapsed ovarian cancer.
Kazuhiro TakeharaTakashi MatsumotoJunzo HamanishiKosei HasegawaMotoki MatsuuraKiyonori MiuraShoji NagaoHidekatsu NakaiNaotake TanakaHideki TokunagaKimio UshijmaHidemichi WatariYoshihito YokoyamaYoichi KaseShuuji SuminoAjit SuriHiroaki ItamochiNobuhiro TakeshimaPublished in: Journal of gynecologic oncology (2021)
ClinicalTrials.gov Identifier: NCT03759587.